Georgiamune
Regulating signaling pathways to restore immune balance and fight cancer and autoimmune diseases, utilizing first-in-class assets with a robust pipeline of immunomodulators.
Launch date
Employees
Market cap
-
Enterprise valuation
CAD409—614m (Dealroom.co estimates Aug 2023.)
Gaithersburg Maryland (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
* | $75.0m | Series A | |
| Total Funding | CAD102m | ||